Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Cohn

Showing results (11-20 of 410) with videos related to

Pageof 41
Sort By:
American Heart Journal|April 1, 1982
Vasodilator therapy: implications in acute myocardial infarction and congestive heart failureJ N Cohn
Circulation|March 1, 1980
Vasodilators in congestive heart failureJ N Cohn
Acta Medica Scandinavica. Supplementum|January 1, 1981
Pathophysiological considerations in selecting vasodilator therapy for CHFJ N Cohn
Cardiology|August 18, 1999
Improving outcomes in congestive heart failure: Val-HeFT. Valsartan in Heart Failure TrialJ N Cohn
American Journal of Hypertension|June 1, 2000
Heart failure: future treatment approachesJ N Cohn
Cardiovascular Drugs and Therapy|August 1, 1995
New concepts regarding events that lead to end-stage heart diseaseJ N Cohn
The New England Journal of Medicine|August 15, 1996
The management of chronic heart failureJ N Cohn
Journal of Cardiac Failure|June 1, 1996
Information vs knowledgeJ N Cohn
The New England Journal of Medicine|September 3, 1992
The prevention of heart failure--a new agendaJ N Cohn
Circulation|May 15, 1995
Structural basis for heart failure. Ventricular remodeling and its pharmacological inhibitionJ N Cohn
Pageof 41

Showing results (11-20 of 410) with videos related to

Sort By:
Pageof 41
American Heart Journal|April 1, 1982
Vasodilator therapy: implications in acute myocardial infarction and congestive heart failureJ N Cohn
Circulation|March 1, 1980
Vasodilators in congestive heart failureJ N Cohn
Acta Medica Scandinavica. Supplementum|January 1, 1981
Pathophysiological considerations in selecting vasodilator therapy for CHFJ N Cohn
Cardiology|August 18, 1999
Improving outcomes in congestive heart failure: Val-HeFT. Valsartan in Heart Failure TrialJ N Cohn
American Journal of Hypertension|June 1, 2000
Heart failure: future treatment approachesJ N Cohn
Cardiovascular Drugs and Therapy|August 1, 1995
New concepts regarding events that lead to end-stage heart diseaseJ N Cohn
The New England Journal of Medicine|August 15, 1996
The management of chronic heart failureJ N Cohn
Journal of Cardiac Failure|June 1, 1996
Information vs knowledgeJ N Cohn
The New England Journal of Medicine|September 3, 1992
The prevention of heart failure--a new agendaJ N Cohn
Circulation|May 15, 1995
Structural basis for heart failure. Ventricular remodeling and its pharmacological inhibitionJ N Cohn
Pageof 41